Effect of Customized Healing Abutment on Soft Tissue Alterations Around Immediate Implant Placements With or Without Bone Graft Versus Connective Tissue Graft

Sponsor
Cairo University (Other)
Overall Status
Completed
CT.gov ID
NCT05975515
Collaborator
(none)
43
1
3
16.5
2.6

Study Details

Study Description

Brief Summary

Dimensional changes, including the loss of labial soft tissues and midfacial gingival recession, seem to be inevitable following immediate placement. The clinical relevance of this study is proposing a treatment modality namely customized healing abutment with immediate implant placement that is proposed to minimize and control midfacial gingival recession and support buccal soft tissue contour, and maintain long term stability of these tissue, which might enhance the esthetics

Condition or Disease Intervention/Treatment Phase
  • Procedure: Connective tissue graft /Bone graft/ Customized HA
N/A

Detailed Description

Tooth extraction is followed by ridge alteration and soft tissue collapse and recession. Different strategies were proposed to limit this collapse however, the ability of these techniques to mimic the original soft tissue level and to maintain long term stability is unclear (Slagter et al., 2014). Using customized contoured healing abutments at the time of immediate implant placement is a treatment modality to improve esthetics by maintaining the soft tissue level and contour (Ruales-Carrera et al, 2019, Perez et al, 2020). Using connective tissue grafts has been suggested to enhance and maintain soft tissue stability, however, the effect of the combined procedures for maintenance of the soft tissue morphology compared to customized healing abutments alone remains unclear (Atieh et al, 2019).

Study Design

Study Type:
Interventional
Actual Enrollment :
43 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomized controlled clinical trial, parallel groups, three-arm, superiority trial with 1:1:1 allocation ratio.Randomized controlled clinical trial, parallel groups, three-arm, superiority trial with 1:1:1 allocation ratio.
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Effect of Customized Healing Abutment on Soft Tissue Alterations Around Immediate Implant Placements With or Without Bone Graft Versus Connective Tissue Graft. A 1-Year Randomized Clinical Trial
Actual Study Start Date :
Jan 13, 2022
Actual Primary Completion Date :
Apr 30, 2023
Actual Study Completion Date :
May 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: immediate implant placement with bone grafts till crest

Group1 (control group): immediate implant placement with bone grafts till crest and customized healing abutment.

Procedure: Connective tissue graft /Bone graft/ Customized HA
Soft tissue management and augmentation
Other Names:
  • Customized Healing abutment
  • Experimental: immediate implant placement with customized healing abutment

    Group 2 (intervention 1 group): immediate implant placement with customized healing abutment

    Procedure: Connective tissue graft /Bone graft/ Customized HA
    Soft tissue management and augmentation
    Other Names:
  • Customized Healing abutment
  • Experimental: immediate implant placement with CTG and customized healing abutment.

    Group 3 (intervention 2 group): immediate implant placement with CTG and customized healing abutment.

    Procedure: Connective tissue graft /Bone graft/ Customized HA
    Soft tissue management and augmentation
    Other Names:
  • Customized Healing abutment
  • Outcome Measures

    Primary Outcome Measures

    1. Mid facial recession [12 months]

      will be assessed by measuring the distance between level of soft tissues at mid-facial gingival level of the implant site and a reference line, which connected the facial soft tissue level of the adjacent teeth, at baseline, 3, 6 and 12 months of follow up.

    Secondary Outcome Measures

    1. Bucco-palatal bone width [12 months]

      Two CBCT scans will be done, primary (preoperative) scan and secondary (Postoperative) scan 12 months after, using Cranex ® SOREDEX, Finland.

    2. Volumetric analysis of buccal contour [12 months]

      To evaluate tissue volume changes in the buccal soft tissue contour in comparison to the original ones, at 2,4 and 6 mm from the pre-operative gingival margin, at 3, 6 and 12 months and will be compared to the presurgical scanned casts

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 50 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Patient-related criteria:

    • Adults at or above the age of 18.

    • Non-restorable maxillary anterior or premolar tooth requiring extraction and needed an implant placing therapy.

    • The failing tooth will have adjacent and opposing natural teeth.

    • Sufficient mesial-distal and interocclusal space for placement of the implant and definitive restoration.

    • Able to tolerate surgical periodontal procedures.

    • Good oral hygiene.

    • Compliance with the maintenance program.

    • Provide informed consent.

    • Accepts the one-year follow-up period.

    Teeth related criteria:
    • Intact thick biotype gingival tissue with at least 2mm band of keratinized tissue.

    • Intact socket wall before the extraction, buccal bone thickness ≤1mm assessed by CBCT.

    • Sufficient apical bone to place an immediate implant with minimum primary stability of 30Ncm

    Exclusion Criteria:
    • Patients diagnosed with periodontal diseases.

    • Current or previous smokers.

    • Pregnant and lactating females.

    • Patients with medical conditions that would compromise the surgical procedures; uncontrolled diabetes mellitus, taking IV Bis-phosphonates for treatment of osteoporosis.

    • Patients with active infection related at the site of implant/bone graft placement.

    • Patients with parafunctional habits

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 IDCE Cairo Egypt

    Sponsors and Collaborators

    • Cairo University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Ahmed Aboulfettouh, Dr. Ahmed Ibrahim AboulFettouh, Cairo University
    ClinicalTrials.gov Identifier:
    NCT05975515
    Other Study ID Numbers:
    • PER 2612
    First Posted:
    Aug 4, 2023
    Last Update Posted:
    Aug 4, 2023
    Last Verified:
    Jul 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No

    Study Results

    No Results Posted as of Aug 4, 2023